We are thrilled to announce that Joseph Cianflone has joined Dova Health Intelligence as our Chief Financial Officer. Joe brings over 20 years of experience as a strategic CFO, investor, advisor, and board member, with a strong track record of scaling businesses across healthcare technology, value-based care, asset management, and impact innovation.
Joe is known for his growth-oriented leadership and his ability to navigate complex capital markets, scale venture and growth-stage companies, and create sustainable enterprise value. His deep expertise spans financial strategy, board and investor relations, analytics, healthcare innovation, and information systems development.
Prior to joining Dova, Joe served as CFO of Nexus Health, a Santa Fe-based multi-specialty medical center. He also led strategic finance at Pearl Health, a Top 50 U.S. startup backed by a16z and AlleyCorp, where he supported transformative growth in value-based care enablement and built critical deal underwriting, M&A, and governance infrastructure.
Joe’s earlier career includes roles as a trader and hedge fund manager at PSP Investments and Orbis Investment Management, as well as Black Diamond Asset Management where he helped launch and register the firm, oversaw regulatory, financial, and investment functions as a partner. His diverse career also includes a CFO role at an innovative cleantech firm remediating otherwise hazardous waste for leading aerospace and industrial giants.
Joe holds an M.Sc. from the University of Oxford’s Saïd Business School, where he was named to the Dean’s List, and a joint A.B. in Economics & Mathematics from Harvard College, graduating cum laude with joint-high honors. He is a CFA Charterholder and a proud Canadian and EU citizen, fluent in English and French, and conversational(-light!) in Italian and Spanish.
Please join us in welcoming Joe to the Dova team. His leadership will be instrumental as we continue advancing our mission to transform gastrointestinal care and pharmaceutical research through AI-driven innovation.
